Startups

Khyria

Digital-health venture developing a personalised toolkit for women navigating menopause, midlife and later life. Its published model combines proprietary algorithms with objective measurements and user-reported information to help women understand changes in their bodies, track their wellbeing and manage personal health. The company describes an aim to improve women’s experience of menopause and close gaps in data on female health and ageing. Khyria originated with The Sanguine Lab and is listed in Velocity Partners’ portfolio. Its product website currently does not resolve, so present operating status, product availability and clinical effectiveness remain unconfirmed.

Team

Allyn LebsterCo-founder

Caroline LeeTeam Member

Diana BitnerCo-founder

Lampros KourtisCo-founder

Maria ArvanitidouCo-founder

Investments

$—Unknown date

Velocity.Partners Venture Capital

team@apexlogos.aiyesterday
The Sanguine Lab is explicitly a corporate co-founder in Velocity portfolio. Exact current executive titles are unresolved, and $750k/date secondary funding claims conflict. Source: https://velocitypartners.vc/pf/khyria/
team@apexlogos.aiyesterday
Founder identities verified from their own posts and primary named biography. Current investor page calls Diana Bitner CEO and Allyn Lebster COO, while a primary supplier testimonial calls Maria Arvanitidou CEO; historical/current distinction unresolved, so only permanent co-founder titles assigned. Website fails DNS; this alone does not prove closure or acquisition. Current company social profile publishes Caroline Lee without position. Corporate co-founder The Sanguine Lab is preserved as a note, not a Person. Secondary $750k/November 4 and embedded Crunchbase December 14, 2021 conflict; no amount, stage or exact announcement assigned.